Status:

UNKNOWN

Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19

Lead Sponsor:

Fundación Santa Fe de Bogota

Conditions:

Sars-CoV2

Covid-19

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected the global population with significant morbidity and mortality. One of the main concerns is the management of the patients...

Detailed Description

This is a Phase II/III randomized clinical trial to assess the effectiveness and safety of anti-SARS-CoV-2 convalescent plasma in i) hospitalized adult patients with high-risk of progression SARS-CoV-...

Eligibility Criteria

Inclusion

  • All patients
  • Patients diagnosed with COVID-19 infection by RT-PCR technique
  • Patients ≥ 18 years of age
  • Patients in standard care according to the national guide
  • Onset of symptoms ≤ 14 days
  • Signature of informed consent report
  • Patients at high risk of progression, defined by all of the following:
  • Score greater than 9 on the CALL scale
  • Pao2 / Fio2 ≤ 200 (parameters adjusted to the height of Bogotá, Colombia)
  • X-ray or CT compatible with pneumonia
  • Hospitalized patients
  • Critically ill patients, defined by any of the following:
  • Mechanical ventilation requeriment
  • Patients in Intensive Care Unit or Intermediate Care Unit
  • Ventilatory failure, septic shock, dysfunction or multi-organ failure

Exclusion

  • Negative RT-PCR result from secretion 48 hours prior to study recruitment
  • History of allergic reaction to blood or plasma in patients with a known history of IgA deficiency
  • Patients participating in other clinical trial
  • History of allergy to blood products
  • History of confirmed infection and that required antibiotic or antifungal treatment 30 days prior to recruitment
  • Pregnant women

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2021

Estimated Enrollment :

236 Patients enrolled

Trial Details

Trial ID

NCT04425837

Start Date

July 1 2020

End Date

February 1 2021

Last Update

June 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fundación Santa Fe de Bogotá

Bogotá, Cundinamarca, Colombia, 110111